Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the significant progress made in the last 10 years in understanding a broad range of rare diseases and translating this knowledge into groundbreaking therapies for a variety of patient populations.
The report illustrates that more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350554-phrma-report-innovation-rare-diseases/
Safe Horizon, the nation’s largest victim services agency, has opened a new Child Advocacy Center (CAC) in the Bronx, with significant support from the de Blasio Administration. This center will be staffed by experts from Safe Horizon, the Administration for Children’s Services, the New York Police Department, the Bronx District Attorney’s Office, the New York City Law Department and Montefiore Medical Center. Together, this team of experts will investigate and respond to the most serious cases of sexual and severe physical child abuse in the Bronx.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7448051-safe-horizon-child-advocacy-center/
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Today, the Television Bureau of Advertising (TVB), the not-for-profit trade association of America’s commercial broadcast television industry, the National Highway Traffic Safety Administration (NHTSA), and the Ad Council launched their 11th year of “Project Roadblock: Local TV Puts the Brakes on Drunk Driving.” Launched in December 2003, Project Roadblock is the local broadcast television industry’s extension of NHTSA and the Ad Council’s ‘Buzzed Driving is Drunk Driving’ PSA campaign. Since then, the multi-media campaign has served as an opportunity for local television stations to combat drunk driving by donating on-air, online and mobile advertising time and space for the PSAs. To date, broadcast TV stations across the nation have donated more than $34 million in media to support this effort.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7391951-ad-council-tvb-nhtsa-partner-to-prevent-drunk-driving-fatalities-during-holidays/
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
The U.S. Environmental Protection Agency (EPA) has proposed sweeping regulations that would require states to reduce carbon dioxide emissions from the electricity sector by an average of 30 percent nationally. This costly plan is another step in the administration's policies designed to eliminate low cost and reliable electricity and replace it with more expensive and less reliable sources.
"The rule is a stunning attempt to remake the nation's entire electric grid at great cost to households and businesses across the US. Our manufacturing base will become less competitive because of higher electricity prices. The impact of this regulation will be felt by families as they will spend more to heat and cool their homes. Those on fixed incomes and seniors will be forced to pay a disproportionately higher share of their monthly budget on utilities," said Hal Quinn, president and CEO, National Mining Association."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7221731-national-mining-association-americans-electricity-bill-increase-due-to-epa-regulations/
In an effort to increase awareness of the Making Home Affordable® (MHA) Program’s free resources and assistance for struggling homeowners, the U.S. Department of the Treasury (Treasury), the U.S. Department of Housing and Urban Development (HUD), and the Ad Council today launched a new series of public service advertisements (PSAs) as a part of their Foreclosure Prevention Assistance campaign.
MHA launched in 2009 and is a critical part of the Administration's strategy to help homeowners avoid foreclosure, stabilize the country’s housing market, and improve the nation's economy. The program offers a range of solutions, including lower monthly mortgage payments for struggling homeowners, as well as options for unemployed or underemployed homeowners and those who owe more than their homes are worth. To date, MHA has helped more than 1.5 million families nationwide.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7324251-ad-council-treasury-hud-new-public-service-ads-making-home-affordable/
As Child Passenger Safety Week wraps up, the U.S. Department of Transportation's National Highway Traffic Safety Administration (NHTSA) is launching a new Car Seat Finder Tool, adding the ability to look up car seat recalls on its mobile app, and reminding parents and caregivers to register their child's car seat through its new campaign – “Don't Delay. Register Your Car Seat Today.” Every 34 seconds, a child under the age of 13 is involved in a crash and more than a third of children killed in crashes were not in car seats or wearing seat belts. NHTSA's new Car Seat Finder Tool is aimed at helping parents select the right car seat or booster seat for their child, while the campaign reminds everyone of the importance of registering car seats to receive important safety recall notifications.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310151-ad-council-nhtsa-child-passenger-safety-2014/
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
To help kids make healthful dietary choices, the U.S. Food and Drug Administration encourages kids to Read the Label!
The Nutrition Facts Label is a simple tool available on food and beverage packages. It lets kids know exactly what they’re eating and helps them choose and compare snacks and other foods. The earlier they start using the Nutrition Facts Label, the sooner they’ll be making choices that keep them feeling great and promote long-term good health!
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7106353-fda-national-childhood-obesity-month/
UBM Tech today introduced the new community-driven Insurance & Technology (insurancetech.com), an interactive platform for insurance technology professionals to connect with peers, editors and industry experts. The redesigned site provides the latest news, commentary and discussion on the most pressing issues that technology and business leaders face in the insurance marketplace. Complementing the brand’s award-winning editorial is perspective from more than 50 community contributors and subject matter experts involved in channel strategies, security, data management, compliance, policy administration, claims and underwriting.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7302151-ubm-tech-introduces-the-new-insurance-and-technology-interactive-platform/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
